SCM
RVMD icon

Sio Capital Management’s Revolution Medicines RVMD Stock Holding History

Sio Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-72,700
Closed -$2.01M – 55
2023
Q3 		$2.01M Buy
+72,700
New +$2.16M 0.62% 32
2023
Q2 		– Sell
-125,957
Closed -$2.73M – 56
2023
Q1 		$2.73M Buy
+125,957
New +$3.1M 1.35% 16

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Sio Capital Management's RVMD Position: Q4 2023 in Review

Sio Capital Management sold out of Revolution Medicines (RVMD) in Q4 2023, closing a stake of 72,700 shares — an estimated $2.01M sold.

Sio Capital Management first reported a position in RVMD in Q1 2023 and held it in 2 quarters. The position peaked at $2.73M in Q1 2023. 184 funds tracked by Wall St. Rank hold RVMD as of Q4 2023.

  • Sio Capital Management reported no remaining Revolution Medicines position as of Q4 2023 after selling out during the quarter.
  • Sio Capital Management sold 72,700 Revolution Medicines shares in Q4 2023, an estimated $2.01M.
  • Sio Capital Management first reported a position in Revolution Medicines in Q1 2023 and held it in 2 quarters.
  • Sio Capital Management's Revolution Medicines position peaked at $2.73M in Q1 2023.
  • 184 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2023.

Based on Sio Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.